Liege, Belgium, 21 March 2022 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that it has exercised a second drawing request for an amount of EUR 5 million, according to the terms of the equity funding agreement signed with Goldman Sachs […]
https://www.mithra.com/wp-content/uploads/2022/03/MicrosoftTeams-image-3.jpg10801920Maud Vanderthommenhttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngMaud Vanderthommen2022-03-21 17:45:582022-03-21 17:16:50Exercise of a Second Drawing Request under Equity Funding Agreement with Goldman Sachs
Liege, Belgium, 08 March 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces its financial results for the year ended 31 December 2021, prepared in accordance with IFRS.
Liege, Belgium, 28 February 2022 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
https://www.mithra.com/wp-content/uploads/2022/02/pexels-ekaterina-bolovtsova-6077600-scaled-e1646056370398.jpg12801920Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-28 17:45:492022-02-28 14:54:07Publication of a Transparency Notification Received from François Fornieri
Liege, Belgium, 25 February 2022 – 7:35 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]
https://www.mithra.com/wp-content/uploads/2020/02/shutterstock_692559100.jpg12801920Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-25 07:35:392022-02-25 00:36:08Publication of a Transparency Notification Received from Alychlo
Liege, Belgium, 25 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
https://www.mithra.com/wp-content/uploads/2022/01/pexels-brotin-biswas-518543-min.jpg17072560Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-25 07:30:032022-02-24 23:58:51Publication of a Transparency Notification Received from Goldman Sachs
Liege, Belgium, 21 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health announces that it will host a live webcast on Tuesday, 8 March 2022 at 09:00 CET to present its 2021 financial and operating results. The live webcast can be accessed on the Mithra website or by […]
https://www.mithra.com/wp-content/uploads/2020/03/Webcast-2020.jpg12502000Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-21 07:30:062022-02-18 11:29:19Mithra to Host Webcast for 2021 Financial Results on 8 March 2022
LIEGE (Belgium – 7:30 AM CET) and MONTREAL (Canada – 7:00 AM EST), February 16, 2022 – Mithra and Searchlight Pharma are pleased to announce the commercial launch of Mithra’s vaginal contraceptive ring Myring® under the brandname Haloette® in Canada.
https://www.mithra.com/wp-content/uploads/2020/05/Canada-1.jpg12801920Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-16 07:30:342022-02-15 17:06:48Mithra and Searchlight Pharma Announce Launch of Haloette® in Canada
Liege, Belgium, 16 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
https://www.mithra.com/wp-content/uploads/2020/03/CP-090320.jpg13332000Maud Vanderthommenhttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngMaud Vanderthommen2022-02-16 07:29:072022-02-15 17:31:07Publication of a Transparency Notification Received from François Fornieri
Liege, Belgium, 14 February 2022 – 17:45 CET – In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below […]
https://www.mithra.com/wp-content/uploads/2020/02/shutterstock_692559100.jpg12801920Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-14 17:45:082022-02-11 11:58:29Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
Liege, Belgium, 7 February 2022 – 07:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it has entered into an equity financing agreement with Goldman Sachs International (“GSI”), pursuant to which the Company can at its sole discretion require GSI (subject to […]
https://www.mithra.com/wp-content/uploads/2020/06/19062020.jpg10801920Célia Berlemonthttps://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.pngCélia Berlemont2022-02-07 07:30:532022-02-06 23:32:15Mithra Obtains Equity Funding for up to EUR 100 Million
Exercise of a Second Drawing Request under Equity Funding Agreement with Goldman Sachs
CorporateLiege, Belgium, 21 March 2022 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that it has exercised a second drawing request for an amount of EUR 5 million, according to the terms of the equity funding agreement signed with Goldman Sachs […]
Mithra Reports Full Year 2021 Financial Results
NewsLiege, Belgium, 08 March 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces its financial results for the year ended 31 December 2021, prepared in accordance with IFRS.
Publication of a Transparency Notification Received from François Fornieri
NewsLiege, Belgium, 28 February 2022 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
Publication of a Transparency Notification Received from Alychlo
NewsLiege, Belgium, 25 February 2022 – 7:35 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]
Publication of a Transparency Notification Received from Goldman Sachs
NewsLiege, Belgium, 25 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
Mithra to Host Webcast for 2021 Financial Results on 8 March 2022
NewsLiege, Belgium, 21 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health announces that it will host a live webcast on Tuesday, 8 March 2022 at 09:00 CET to present its 2021 financial and operating results. The live webcast can be accessed on the Mithra website or by […]
Mithra and Searchlight Pharma Announce Launch of Haloette® in Canada
NewsLIEGE (Belgium – 7:30 AM CET) and MONTREAL (Canada – 7:00 AM EST), February 16, 2022 – Mithra and Searchlight Pharma are pleased to announce the commercial launch of Mithra’s vaginal contraceptive ring Myring® under the brandname Haloette® in Canada.
Publication of a Transparency Notification Received from François Fornieri
CorporateLiege, Belgium, 16 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]
Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
NewsLiege, Belgium, 14 February 2022 – 17:45 CET – In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below […]
Mithra Obtains Equity Funding for up to EUR 100 Million
NewsLiege, Belgium, 7 February 2022 – 07:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it has entered into an equity financing agreement with Goldman Sachs International (“GSI”), pursuant to which the Company can at its sole discretion require GSI (subject to […]